Search Site
Home >> Signaling Pathways >> Obesity, Appetite Control & Diabetes

Obesity, Appetite Control & Diabetes

Obesity, Appetite Control & Diabetes

Satiety, appetite, and craving are CNS drives, whereas metabolism and energy utilization are peripheral endocrine actions.
Stephen M. Stahl, M.D., Ph.D. read more

Products for  Obesity, Appetite Control & Diabetes

  1. Cat.No. Product Name Information
  2. A1013 Endomorphin-1 Agonist of ╬╝opioid receptors,highly potent and selective
  3. A1024 LEP (116-130) (mouse) An antiobesity hormone
  4. A1119 Secretin (human) New Product, Cas No.:108153-74-8, Please Inquiry
  5. A1121 Melanocyte stimulating hormone release inhibiting factor MSH release-inhibiting factor
  6. A1019 Glucagon (19-29), human Potent Ca2+/Mg2+-ATPase inhibitor
  7. A1025 a-MSH, amide Melanocyte-stimulating hormones
  8. A1113 Diazepam-Binding Inhibitor Fragment, human New Product, Cas No.:104360-70-5, Please Inquiry
  9. A1115 Peptide YY(3-36), PYY, human Y2R agonist
  10. A1134 Agouti-related Protein (AGRP) (25-82), human Agouti-related peptide(25-82)

9 Item(s)

per page

Set Descending Direction